| Bioactivity | Nizubaglustat is an inhibitor of Ceramide Glucosyltransferase or Glucosylceramide Synthase (GCS). Nizubaglustat also inhibits GBA2, involving in neuropathological lysosomal storage disorders[1][2]. |
| Name | Nizubaglustat |
| CAS | 1633666-49-5 |
| Formula | C24H32FNO5 |
| Molar Mass | 433.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ghisaidoobe AT, et al. Identification and development of biphenyl substituted iminosugars as improved dual glucosylceramide synthase/neutral glucosylceramidase inhibitors. J Med Chem. 2014 Nov 13;57(21):9096-104. [2]. WHO Drug Information-World Health Organization (WHO). |
Nizubaglustat
CAS: 1633666-49-5 F: C24H32FNO5 W: 433.51
Nizubaglustat is an inhibitor of Ceramide Glucosyltransferase or Glucosylceramide Synthase (GCS). Nizubaglustat also inh
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.